# Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

> **NCT02682381** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 59 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Teduglutide 0.05mg/kg
- **DRUG:** Teduglutide 0.025 mg/kg
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT02682381
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-23
- **Primary completion:** 2017-08-18
- **Final completion:** 2017-08-18
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682381, "Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT02682381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*